BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
Market News

Diebold (NYSE: DBD): Q3 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected. — Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is […]

October 29, 2019 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected. — Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is […]

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected.

— Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is hurting customer demand for Retail solutions.

Earnings Update by AlphaStreet

— Sales from Eurasia Banking declined by 7% while that from the Americas Banking increased by 6%. Total retail sales fell by 11%.

— Looking ahead into the full year 2019, the company lowered its total revenue outlook to about $4.4 billion from the previous estimate of about $4.5 billion.

— Adjusted EBITDA is now expected to be in the range of $400 million to $410 million compared to the prior forecast range of $400 million to $420 million.

— Net cash provided by operating activities is now predicted to be in the $120 million to $150 million range, up from the earlier forecast of about $100 million.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT